iShares Genomics Immunology and Healthcare ETF
IDNA----
iShares Genomics Immunology and Healthcare ETF (IDNA)
IDNA tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering.
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- PUBT · 21 hours ago
Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancer
- Barchart Option · 5 hours ago
Earnings Preview: What To Expect From Moderna’s Report
- prnewswire · 1 day ago, 03:28 PM
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS
- Tip Ranks · 19 hours ago
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price Target
- Pharmaceutical Business Review · 2 days ago, 04:15 AM
Halozyme and Incyte sign licence agreement for INCA033989 formulations
- MorningStar · 2 days ago, 04:04 AM
FairJourney Bio Announces Scientific Program and Leadership for The Antibody Series 2026
